Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

BACKGROUND: Renal replacement therapy was a lifesaving yet high-cost treatment for people with end-stage kidney disease (ESKD). This study aimed to estimate the direct medical costs per capita of ESKD by different treatment strategies: haemodialysis (HD); peritoneal dialysis (PD); kidney transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Zhang, Chao, Zhu, Sufen, Ye, Hongjian, Zhang, Donglan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023821/
https://www.ncbi.nlm.nih.gov/pubmed/32059726
http://dx.doi.org/10.1186/s12913-020-4960-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023821/
https://www.ncbi.nlm.nih.gov/pubmed/32059726
http://dx.doi.org/10.1186/s12913-020-4960-x

Ejemplares similares